Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
+1 212 318 2000
Europe, Middle East, & Africa
+44 20 7330 7500
+65 6212 1000
Biotech is the industry that is attracting the most venture capital dollars, according to the latest stats from the National Venture Capital Association. So wouldn’t it make sense that science PhDs could be poised to become the 21st century version of the Google Guys? Meaning, pursuing a science PhD or an MD in 2009 could be the right training for an inventive entrepreneur, parallel to studying computer science in 1999.
At least that’s the thinking behind new fellowships being granted by the Ewing Marion Kauffman Foundation. The organization announced today that it’s awarding 13 postdoctoral researchers the financial and mentorship support to commercialize their scientific findings.
I met recently in New York with Lesa Mitchell, the Kauffman Foundation’s vice president of Advancing Innovation. “The economic recovery will happen through entrepreneurship, which can help fuel growth,” she said. “We want to help build a pipeline between PhDs and MDs and VCs.”
The thirteen Kauffman Foundation fellows are (after the jump):
• Ankit Agarwal, University of Wisconsin-Madison
• Vijay Chandrasekharan, University of Florida
• David Gruber, Brown University, City University of New York
• Yash Kolambkar, Georgia Institute of Technology
• Riccardo LoCascio, University of California, Davis
• Timothy Marzullo, University of Michigan
• Samuel Mazin, Stanford University
• Franklin Moutos, Duke University
• Christopher Rex, University of California, Irvine
• Carolina Salvador Morales, Harvard Medical School
• Praveen Kumar Vemula, Harvard Medical School
• Yevgen Voronenko, Carnegie Mellon University
• Mehdi Yazdanpanah, University of Louisville
Extensive biographies are available on the Kauffman Foundation site. Smart companies and investors will pay attention to their work, if not only to recruit them directly, but also to seek new markets in biotech.
What comes next? The Bloomberg Businessweek Innovation and Design blog chronicles new tools for creativity and collaboration, innovation case studies in both the corporate and social sectors, and the new ideas that have the power to change the way things have always been done.